Notification of Major Interest by Legal & General

21st March 2017 - 5:01 pm

ImmuPharma PLC (LSE:IMM) (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc (“L&G”) confirming its holding in ImmuPharma of  4,446,545 million Ordinary Shares in the capital of the Company, representing 3.35% of ImmuPharma’s total voting rights figure of  132,522,985 Ordinary Shares.

Commenting, Tim McCarthy, Chairman of ImmuPharma, said: “We are delighted to be able to disclose Legal & General’s increased holding in ImmuPharma as one of our existing major institutional investors which participated in our recent successful £4.1 million fundraising demonstrating its continued support for ImmuPharma.”

For full disclosure of the TR1: IMM L&G interest in shares March 2017

 

Share this article